Exploring regulatory network of metabolism through liver research Motoharu Awazawa Review Article 26 August 2021 Pages: 343 - 348
Translational research on human pancreatic β-cell mass expansion for the treatment of diabetes Jun Shirakawa Review Article 17 August 2021 Pages: 349 - 355
Association of glycemic control and anthropometric measurement among type 2 diabetes mellitus: a cross-sectional study Mitku Mammo TaderegewMamo Solomon EmeriaBetregiorgis Zegeye Original Article 25 January 2021 Pages: 356 - 363
Comprehensive efficacy of ipragliflozin on various conditioned type 2 diabetes compared with dipeptidyl peptidase-4 inhibitors and with both agents, based on a real-world multicenter trial Fumio SawanoNozomu KameiTadahiro Kitamura Original Article 11 February 2021 Pages: 364 - 378
Determinants of type 2 diabetes remission after bariatric surgery in obese Japanese patients: a retrospective cohort study Masahiro OhiraYasuhiro WatanabeIchiro Tatsuno Original Article 28 January 2021 Pages: 379 - 388
Sodium-glucose cotransporter 2 inhibitor canagliflozin attenuates lung cancer cell proliferation in vitro Leona YamamotoShinichi YamashitaAkinori Iwasaki Original Article 16 February 2021 Pages: 389 - 398
Evaluation of multiple drug use in patients with type 2 diabetes mellitus Habibe İnci Original Article 07 February 2021 Pages: 399 - 404
Associations of serum transthyretin with triglyceride in non-obese elderly Japanese women independently of insulin resistance, HDL cholesterol, and adiponectin Satomi Minato-InokawaAyaka TsuboiKeisuke Fukuo Original Article 13 February 2021 Pages: 405 - 411
Prevalence of obesity in prepubertal and pubertal with Turkish population type 1 diabetes Volkan ÖzkayaErdal ErenYasemin Denkboy Öngen Original Article 18 February 2021 Pages: 412 - 419
Increased nutrition-related risk as an independent predictor of the incidence of hypoglycemia in the hospitalized older individuals with type 2 diabetes: a single-center cohort study Yoshinobu KimuraNaoya KimuraManabu Akazawa Original Article 17 February 2021 Pages: 420 - 429
Real-world evidence for long-term safety and effectiveness of ipragliflozin in treatment-naïve versus non-naïve Japanese patients with type 2 diabetes mellitus: subgroup analysis of a 3-year post-marketing surveillance study (STELLA-LONG TERM) Hiroshi MaegawaKazuyuki TobeSatoshi Uno Original Article 24 March 2021 Pages: 430 - 444
Diabetes-related acute metabolic emergencies in COVID-19 patients: a systematic review and meta-analysis Vasileios P. PapadopoulosMarios-Vasileios KoutroulosDimitrios K. Filippou Original Article 23 March 2021 Pages: 445 - 459
Glycemic control status, diabetes management patterns, and clinical characteristics of adults with type 1 diabetes in Japan: Study of Adults’ Glycemia in T1DM subanalysis Norio AbiruAkira ShimadaHiroshi Ikegami Original Article 25 April 2021 Pages: 460 - 473
Clinical features resembling subcutaneous insulin resistance observed in a patient with type 2 diabetes and severe COVID-19-associated pneumonia: a case report Atsushi SatomuraYoichi OikawaAkira Shimada Case Report 01 March 2021 Pages: 474 - 479
Unilateral adrenalectomy partially improved hyperglycemia in a patient with primary bilateral macronodular adrenal hyperplasia Mitsuru NishiyamaTakashi KarashimaShimpei Fujimoto Case Report 10 April 2021 Pages: 480 - 484